Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy.
Curr Drug Targets
; 11(11): 1423-9, 2010 Nov.
Article
in En
| MEDLINE
| ID: mdl-20583975
ABSTRACT
Radiation nephropathy and other normal tissue radiation injuries can be successfully mitigated, and also treated, by antagonists of the renin-angiotensin system (RAS). This implies a mechanistic role for that system in radiation nephropathy, yet no evidence exists to date of activation of the RAS by irradiation. RAS antagonists, including angiotensin converting enzyme inhibitors and angiotensin receptor blockers, are the standard of care in the treatment of subjects with other chronic progressive kidney diseases, in which they exert benefit by reducing both glomerular and tubulo-interstitial injury. These drugs are likely to act in a similar way to mitigate radiation nephropathy.
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Radiation Injuries
/
Renin-Angiotensin System
/
Angiotensin-Converting Enzyme Inhibitors
/
Angiotensin Receptor Antagonists
/
Kidney Diseases
Limits:
Animals
/
Humans
Language:
En
Journal:
Curr Drug Targets
Year:
2010
Document type:
Article